PD-L1 expression combined positive score (CPS) influenced overall survival, supporting the importance of immunotherapy and immune targeting in the treatment of R/M HNSCC, and emphasized the importance of the PD-1/PD-L1 pathway in mediating immune evasion in HNSCC. Here, PDCD1 is linked to head and neck squamous cell carcinoma.